Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer
Open Access
- 14 September 2005
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 117 (3) , 499-505
- https://doi.org/10.1002/ijc.21202
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interferons Inhibit Tumor Necrosis Factor-α-mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-κBJournal of Biological Chemistry, 2002
- Inhibition of Liver Metastasis of Human Pancreatic Carcinoma by Angiogenesis Inhibitor TNP‐470 in Combination with CisplatinJapanese Journal of Cancer Research, 1998
- Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene ExpressionJournal of Biological Chemistry, 1997
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.The Journal of Experimental Medicine, 1996
- The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NRGastroenterology, 1995
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470Inflammation Research, 1993
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990